Form 4: Nuvalent CEO Exercises Stock Options, Acquires 22,000 Shares

Nuvalent's CEO, James Richard Porter, exercised stock options to acquire 22,000 shares of Class A Common Stock at $0.65 per share.

Summary

• James Richard Porter, the President and CEO of Nuvalent, Inc., exercised stock options on December 19, 2024.
• This transaction involved the acquisition of 22,000 shares of Class A Common Stock at a price of $0.65 per share.
• Following this transaction, Mr. Porter directly owns 210,113 shares of Class A Common Stock.
• Additionally, Mr. Porter holds options for 565,942 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction by the CEO, which is generally viewed positively as it aligns management's interests with shareholders. There is no indication of any negative sentiment.

Positives

• The CEO's exercise of stock options demonstrates confidence in the company's future prospects.
• The acquisition of shares increases the CEO's direct stake in the company.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's stock. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option exercises are a common form of executive compensation in publicly traded companies, particularly in the biotech and pharmaceutical sectors.
• The exercise price of $0.65 per share is specific to Nuvalent's stock option plan and is not directly comparable to other companies without knowing their specific option terms.
• The number of shares acquired and the total holdings are specific to this executive and do not provide a basis for comparison to other companies.

Stakeholder Impact

• The transaction increases the CEO's stake in the company, aligning his interests with those of shareholders.
• The exercise of options does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, insider trading, executive compensation, share acquisition, NUVL, Nuvalent, CEO